Patent · US Active

Benzotriazine oxides as drugs targeting Mycobacterium tuberculosis

US9663478B2 · kind B2 · utility

0Cited by
6References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 23, 2012
Grant dateMay 30, 2017
Priority date—
Expiry dateJun 3, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.